Abstract CT132: Trial in progress: A phase 1/2 study of ASP1570, a novel inhibitor of DGKζ, in participants with locally advanced or metastatic solid tumors who have progressed on, or are ineligible for, all available standard therapies
Year: 2023
Type: conference-abstract
Source: Cancer Research
Authors: Manish R. Patel, David J. Park, Stefano Tarantolo, Afshin Dowlati, Daniel Olson, Yuichiro Kaneko, Mei Tang, Serguei Soukharev, Masaomi Takizawa, Yohei Okada, Christine Fredericks, Teresa Flegel, Tsubasa Watanabe, Sue Lee, Jason John Luke
Institutions: St. Jude Medical Center, University Hospitals Seidman Cancer Center, Case Western Reserve University, University of Chicago, University of Chicago Medicine Comprehensive Cancer Center, Astellas Pharma (United States), Astellas Pharma (Japan), UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4365512215